The invention concerns compounds of formula (I)
wherein R1, R2, R3, R4 and R5 are as defined herein. Said compounds are useful in therapy as antithrombotic agents.
Substituted piperazinones and their therapeutic uses
申请人:Laboratoire L. Lafon
公开号:US06335337B1
公开(公告)日:2002-01-01
Novel compounds which are inhibitors of the binding of fibrinogen to the Gp iib/iiia platelet receptors, and which can be used therapeutically as antithrombotic agents.